[1]
L. Mocan Hognogi and L. Simiti, “THE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME”, Medicine and Pharmacy Reports, vol. 89, no. 3, pp. 322-326, Jul. 2016.